Ardelyx, Inc. (ARDX)
3.74
-0.15
(-3.86%)
USD |
NASDAQ |
Aug 24, 16:00
3.77
+0.03
(+0.80%)
Pre-Market: 08:32
Ardelyx Price : 3.74 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 3.88 | 3.89 | 3.725 | 3.74 | 5.217M |
| Aug 21, 2026 | 3.92 | 3.97 | 3.88 | 3.89 | 2.879M |
| Aug 20, 2026 | 4.04 | 4.067 | 3.86 | 3.90 | 4.565M |
| Aug 19, 2026 | 4.02 | 4.07 | 3.944 | 4.03 | 3.050M |
| Aug 18, 2026 | 4.05 | 4.09 | 3.89 | 3.92 | 4.041M |
| Aug 17, 2026 | 4.06 | 4.09 | 4.00 | 4.06 | 3.668M |
| Aug 14, 2026 | 3.93 | 4.07 | 3.86 | 4.06 | 3.978M |
| Aug 13, 2026 | 4.03 | 4.04 | 3.86 | 3.91 | 4.355M |
| Aug 12, 2026 | 3.94 | 4.009 | 3.89 | 3.97 | 4.955M |
| Aug 11, 2026 | 4.02 | 4.09 | 3.92 | 3.94 | 8.167M |
| Aug 10, 2026 | 4.05 | 4.12 | 3.90 | 4.00 | 10.81M |
| Aug 07, 2026 | 4.05 | 4.27 | 3.90 | 4.00 | 20.07M |
| Aug 06, 2026 | 4.89 | 5.00 | 4.815 | 4.87 | 7.283M |
| Aug 05, 2026 | 5.04 | 5.099 | 4.84 | 4.91 | 3.110M |
| Aug 04, 2026 | 5.02 | 5.03 | 4.82 | 5.01 | 3.130M |
| Aug 03, 2026 | 4.98 | 5.025 | 4.88 | 4.98 | 2.919M |
| Jul 31, 2026 | 5.04 | 5.05 | 4.92 | 4.95 | 2.763M |
| Jul 30, 2026 | 4.97 | 5.04 | 4.905 | 5.04 | 2.593M |
| Jul 29, 2026 | 5.08 | 5.096 | 4.97 | 5.00 | 2.183M |
| Jul 28, 2026 | 5.07 | 5.125 | 5.025 | 5.085 | 1.656M |
| Jul 27, 2026 | 5.13 | 5.21 | 5.06 | 5.06 | 1.811M |
| Jul 24, 2026 | 5.15 | 5.17 | 5.02 | 5.03 | 1.720M |
| Jul 23, 2026 | 5.00 | 5.15 | 4.969 | 5.13 | 2.074M |
| Jul 22, 2026 | 5.03 | 5.094 | 5.004 | 5.08 | 2.180M |
| Jul 21, 2026 | 5.09 | 5.115 | 4.98 | 5.09 | 3.795M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| REGENXBIO, Inc. | 8.055 |
| ACADIA Pharmaceuticals, Inc. | 29.65 |
| Alnylam Pharmaceuticals, Inc. | 236.01 |
| Anika Therapeutics, Inc. | 21.34 |
| Savara, Inc. | 5.56 |
Price Related Metrics
| PS Ratio | 2.031 |
| Price to Book Value | 6.253 |
| Earnings Yield | -6.05% |
| Market Cap | 931.81M |